Time New York: Mon 24 Sep 13:02 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Apogee Plans Restructuring, To Shut Down Viracon Glass Plant

Zacks

Apogee Enterprises, Inc. APOG recently announced details of the planned restructuring which was referred to in the third-quarter fiscal 2018 earnings release. Per the plan, the company will close its Viracon architectural glass plant in St. George, UT, to counter the headwinds of the glass business.

The company remains confident that despite the closure, given the capacity additions and productivity investments made over the past five years, the company will have adequate glass capacity to cater to the peak commercial construction market demand.

In the fiscal third-quarter earnings release, Apogee lowered the fiscal 2018 guidance due to lower-than-expected volume and pricing in the Architectural Glass segment. In the recently-reported quarter, the segment’s revenues fell 9% year over year, largely due to delays resulting from hurricanes in Florida and a smaller number of large-scale projects. Further, the segment’s operating income dropped as improved productivity couldn't offset the loss of business.

Apogee Enterprises, Inc. Price

Apogee Enterprises, Inc. Price | Apogee Enterprises, Inc. Quote


However, Apogee has been making significant investments in its Viracon architectural glass business, weakness in the architectural glass area remains a major concern for the business. Apogee expects that the Architectural Glass segment will be adversely affected by the intensifying competition in both large- and mid-sized projects, in turn putting more pressure on top- and bottom-line growth.

Thus, the company has decided to close the Viracon-St. George facility in March 2018. Apogee will incur a restructuring charge of approximately $4.5 million, or 11 cents per share in the fiscal 2018 fourth quarter, primarily related to the plant closure. This was reflected in the fiscal 2018 outlook. It expects a payback period of one year and the glass business will be beneficial as reduced cost will result in savings in fiscal 2019.

Moreover, Apogee has underperformed the industry with respect to price performance over the past year. The stock has lost around 15.3%, while the industry has recorded growth of 10.2% during the same time frame.



Apogee currently carries a Zacks Rank #4 (Sell).

Better-ranked stocks in the same sector include Deere & Company DE, Kennametal Inc. KMT and Caterpillar Inc. CAT. While Deere sports a Zacks Rank #1 (Strong Buy), Kennametal and Caterpillar carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Deere has a long-term earnings growth rate of 8.2%. Its shares have rallied 25.1%, over the past six months.

Kennametal has a long-term earnings growth rate of 8.3%. The company’s shares have been up 28% during the same time frame.

Caterpillar has a long-term earnings growth rate of 10.3%. Shares of the company have appreciated 50% during the same time period.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.

Automatically Feed Your Blog